Night-Time Acid Reflux Can Impact Sleep, New Studies Reveal
According to results of a survey presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology, nighttime acid reflux, along with some of the less typical manifestations or symptoms of gastroesophageal reflux disease (GERD), is associated with significant sleep impairment.
Wyeth Receives FDA Approval Of Protonix For Delayed Release Oral Suspension
Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), announced that the U.S. Food and Drug Administration (FDA) has approved Protonix (pantoprazole sodium) For Delayed-Release Oral Suspension, a new addition to the Protonix family of prescription medications.
Survey Reveals Heartburn Sufferers Experience More Heartburn During The Holidays
Heartburn remains a burning problem for more than 60 million Americans each month(1), and this November, the National Heartburn Alliance (NHBA) is recognizing the need for heartburn education by sponsoring the first ever Heartburn Awareness Month. Recent survey results show that 66% of people experience heartburn symptoms during the holiday season.
Astrazeneca Receives First European Approval For Nexium R In Pediatric Gerd
AstraZeneca announced that it has received Swedish Medical Products Agency (MPA) approval for use of Nexium(R) (esomeprazole) in children aged 1-11 years with gastroesophageal reflux disease (GERD) in the reference member state of Sweden, with other European Union nations expected to follow.
ASGE Offers Guidelines On Endoscopic Treatment Of Dyspepsia
The American Society for Gastrointestinal Endoscopy (ASGE) has issued guidelines for the role of endoscopy in treating dyspepsia, discomfort thought to arise from the upper-gastrointestinal tract, which affects a fourth of the population in Western countries.
Acirc; pound;100m Spent Annually On Pointless Indigestion Drugs By NHS
It is estimated that the National Health Service (NHS) spends at least ^Alb100m per year on needless indigestion drugs, according to an editorial published in the British Medical Journal (BMJ). The UK is not alone in this kind of spending - apparently, almost ^Alb2bn are spent globally on such drugs each year.
Acid Reflux Study Looks At Lifespan Of Sufferers
Gastroesophageal reflux disease (GERD), often known as acid reflux, is a common problem that has been associated with cancers, asthma, recurrent aspiration and pulmonary fibrosis. A new study published in The American Journal of Gastroenterology examines whether GERD sufferers may have shorter lifespans than those without the disease.
Hospitalizations Due To GERD Rose 103 Between 1998 And 2005, USA
The number of people hospitalized because of GERD (gastroesophageal reflux disease) in the USA rose 103% between the period 1998 and 2005, according to details published by the Agency for Healthcare Research and Quality (AHRC). During that same period there was a 216% rise in the number of patients hospitalized for other ailments but who also had milder forms of GERD.
Using Newly Approved Device, Doctors Do incision-less GERD Surgery
If you're constantly reaching for antacids to control your heartburn, you may have a more serious problem called reflux disease. Some 25 million Americans have it* and now they have a new option to treat it. Using a newly-approved device for the first time in the U.
Heartburn Surgery Done Through Patient's Mouth
If you're constantly reaching for antacids to control your heartburn, you may have a more serious problem called reflux disease. Some 25 million Americans have it* and now they have a new option to treat it. Using a newly-approved device for the first time in the U.